Comparative Study Of Healthcare Resource Utilization (HRU) Outcomes Between Chronic Lymphocytic Leukemia (CLL) Patients Treated With Ibrutinib Versus Non-Ibrutinib Treated Patients
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.098
https://www.valueinhealthjournal.com/article/S1098-3015(17)30432-1/fulltext
Title :
Comparative Study Of Healthcare Resource Utilization (HRU) Outcomes Between Chronic Lymphocytic Leukemia (CLL) Patients Treated With Ibrutinib Versus Non-Ibrutinib Treated Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30432-1&doi=10.1016/j.jval.2017.08.098
First page :
A414
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
79